Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells

Conclusions: Taken together, this work presents the novel anticancer candidate WZ35 for the treatment of prostate cancer, and importantly, reveals that increased ROS generation might be an effective strategy in human prostate cancer treatment.

http://www.biomedcentral.com/1471-2407/15/866

Source: BMC Cancer - November 6, 2015 Category: Cancer & Oncology Authors: Xiuhua ZhangMinxiao ChenPeng ZouKarvannan KanchanaQiaoyou WengWenbo ChenPeng ZhongJiansong JiHuiping ZhouLangchong HeGuang Liang Source Type: research

More News: Cancer | Cancer & Oncology | Prostate Cancer